Dent Neurological Institute

Amherst, New York 14226

We've found

5 trials

at this facility

The Childhood and Adolescent Migraine Prevention Study

Status: Enrolling, Phase III
Updated: 11/10/2014

from

Amherst, NY

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Amherst, NY

A Study of LY3154207 in Participants With Parkinson's Disease Dementia

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Amherst, NY

A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Amherst, NY

A Study of Lasmiditan (LY573144) Over Four Migraine Attacks

Status: Upcoming, Phase III
Updated: 12/31/1969

from

Amherst, NY

Use our guide to learn which trials are right for you!